Master List of Professional Electives Course Title Description Credit Hours. Note: This class only meets for the last 7 class periods of the semester.

Similar documents
Doctor of Pharmacy Course Descriptions

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview

CERTIFICATE IN BIOPHARMACEUTICALS

Introduction PART. 1 Why Technicians Need to Study Pharmacology and Therapeutics. 2 Pharmacokinetics

Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research

Pharmacy Courses (College of Pharmacy) (PHAR)

School of Pharmacy TEMPLE UNIVERSITY

INTEGRATED STUDIES, SCIENCE AND BUSINESS VALLEY SANTAKA CENTRE FOR THE ADVANCED PHARMACEUTICAL AND HEALTH TECHNOLOGIES.

PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14

Pharmaceutical Sciences/Medicinal Chemistry, M.S.

Personalised Healthcare Solutions (PHCS) Excellence for your Biomarker-driven Strategies

Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y. Report Price Publication date

Community and Environmental Health

Program of study. pharmacy. 1st year

Message from Genentech s Executive Sponsor

Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education

Post-doctoral PharmD Fellowship Programs

Industry Perspective on Manufacturing in Early Development

Program Assessment. University of Cincinnati School of Social Work Master of Social Work Program. August 2013

Pharmaceutical Industry Research Credit Audit Guidelines

DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY

Pharmaceutical Sciences/Medicinal Chemistry, Ph.D.

Course Outline and Syllabus for Students (2016)

FUTURE MEANS CREATIVITY

From Molecules To Medicine

Building a Career in the Pharmaceutical Industry: Personal Reflections. Carlo Nalin, PhD Executive Director Novartis Oncology

Argosy University, Nashville Campus CMHC Program Review

Molecular Biotechnology Master Degree Program

Konica Minolta to Acquire Invicro (US)

MICROBIO, IMMUN, PATHOLOGY-MIP (MIP)

FIP Education FIPEd Education Development Team EDT

Molecular and Cell Biology (MCB)

Industry Academic Collaboration: A Key to Successful Involvement of Patients Early in Clinical Development

Pharmaceutical Industry Research Credit Audit Guidelines - Revised - 4/30/04

Biology (BIO) Biology (BIO) Courses. Biology (BIO)

The Aptuit Center for Drug Discovery & Development Verona, Italy

COURSES IN ADVERTISING AND PUBLIC RELATIONS

National Standards. Council for Standards in Human Service Education (1980, 2005, 2009)

MASTER OF PUBLIC ADMINISTRATION

Business Administration

MANAGEMENT INFORMATION SYSTEMS

The Promise and Challenge of Adaptive Design in Oncology Trials

MASTER OF HEALTH ADMINISTRATION

UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA

ICH Topic E15 Definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories.

FDA Guidance, Clinical Pharmacology, and Regulatory Science

Reflections on a career in Pharmaceutical Statistical Sciences: My Journey. James R. Johnson, PhD (UD04)

Ph.D. in the Pharmaceutical Sciences Curriculum

School of Fisheries, Aquaculture and Aquatic Sciences

Section I: Pharmaceuticals and Medical Devices

WITA/GWU TRADE SEMINAR September 29, 2016 Washington D.C. RICHARD KJELDGAARD INTELLECTUAL PROPERTY AND TRADE CONSULTANT

Biology (BIOL) Biology BIOL 1620

Biomedical Engineering

Biotechnology. Curriculum. for the Master s Programme in. Programme classification no Universität für Bodenkultur Wien

Life SCIENCE GR ADUATE SCHOOL OF

Biological Sciences (BA, BS and Minor)

PHARMACOLOGY. Dr Paul Spiers, Dept of Pharmacology & Therapeutics Tel ,

Global Development Challenges: Classical and Advanced Therapy Medicinal products

Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Drug Information

2014 Kent State University Catalog - Fall 2014 Course Descriptions Page 940

Management (MGMT) Courses

Clinical Research Programme

International Transfers of Personal Data at sanofi-aventis R & D

Standard 5 Appendix 6

Metropolitan College of New York School for Business

Food and Drug Administration (FDA) 101

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

ATIP Avenir Program 2018 Young group leader

GUIDANCE FOR INDUSTRY ON FIXED DOSE COMBINATIONS (FDCs)

STARTING STRONGER IN PHASE I THROUGH IIA

PRECLINICAL DRUG DISCOVERY AND DEVELOPMENT BIOBOOT CAMP 2016

GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS

Drug Development Services

Early Phase Education WHITEPAPER. Three major items to consider when moving from preclinical to clinical development

Is FMT A Drug? Lance Shea, M.S., J.D. Washington Square, Suite Connecticut Ave., NW Washington, DC, D

Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE

MEDICAL PHYSICS (MED PHYS)

Biomedical Engineering Graduate Program

CERMONY SPLITS BY PROGRAMME

Utilizing Innovative Statistical Methods. Discussion Guide

Defining Clinical Benefit in Clinical Trials: FDA Perspective

Standard 5 Matching Operations with the Mission: Student Learning

BIOMOLECULAR SCIENCE PROGRAM

Formulation Development of New Chemical Entities (NCEs) Dr. Mariella Artusi Pharmaceutical Development Dept. Monza

Complex Generics: Charting a new path

Course Catalog - Spring 2015

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

1.4 Applicable Regulatory Requirement(s) Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational products.

BIOMEDICAL ENGINEERING (BMED)

Glossary of Abbreviations

Supply Chain Management

VIA University College. Curriculum BA of International Sales and Marketing

Course Descriptions. BIOL: Biology. MICB: Microbiology. [1]

STRATEGIC HUMAN RESOURCES

Novartis Business Services HR University Relations. Clinical Sciences and Innovation. Postgraduate Program

PAREXEL GENOMIC MEDICINE SERVICES. Applying genomics to enhance your drug development journey

PROGRAMME SPECIFICATION KEY FACTS. Programme name Corporate Finance. Cass Business School Department or equivalent Specialist Masters Programme

PROGRAMME SPECIFICATION UNDERGRADUATE PROGRAMMES KEY FACTS. School of Arts and Social Sciences Department or equivalent Department of Psychology

COURSE DESCRIPTIONS: EMS ADMINISTRATION

Celerion s Symposia Series: Bridging the Gap from Phase I to Proof-of-Concept. San Francisco, CA Tue 8 th, Apr 2014

Transcription:

Course Number PHTH7044 PHRX7064 PHRX704C PHRX706 PHTH8048 PHRX 904 PHRX 904 Master List of Professional Electives Course Title Description Credit Hours Advanced Cardiac Life Support Emphasis (P only) Advanced Topics in Ambulatory Care (Block nd 7 weeks) Advanced Topics in Contemporary Compounding Advocacy & Professionalism in Practice Antithrombotic Therapy Management (P only) Clinical Project I (P4 only) Clinical Project II (P4 only) This course is designed to teach the important concepts related to advanced cardiac life support. The course follows the AHA guidelines for ACLS including hands on evaluation and the Putting It All Together final assessment. Successful completion of written and performance assessments will result in AHA ACLS certification. This course is graded on a pass/fail basis. This course will provide the student with an overview of practice models within ambulatory care pharmacy, including topics on starting new services, writing policies and collaborative practice agreements, and billing for services. In addition to lectures, various activities will allow hands-on experience, preparing the student for advanced pharmacy practice experiences in ambulatory care. Note: This class only meets for the last 7 class periods of the semester. This course will provide the student with an overview of advanced pharmaceutical compounding techniques. Topics will include preparation of various dosage forms, equipment and supplies utilized in compounding, quality assurance and recordkeeping. In addition to lectures, various laboratory-based activities will allow for hands-on experience. Note: This class only meets for the first 7 class periods of the semester. This course is intended to introduce student pharmacists to aspects of leadership and communication for the purpose of advancing advocacy and professionalism in pharmacy. Provides students with a foundation in the principles of thrombosis, thrombotic diseases, and antithrombotic therapy management. A problem-based, clinically-related project that requires integration and application of the didactic coursework and experiential training in order to generate a rational solution to a well-defined question using established scientific methodologies. A problem-based, clinical-related project that requires integration and application of the didactic coursework and experiential training in order to generate a rational solution to a well-defined question using established scientific methodologies.

PHTH704 (5FS.F) Comprehensive Tobacco Dependence Treatment This intensive two-day course provides the student with the skills needed to effectively treat tobacco dependence. The student will develop his/her knowledge and skills to assess, manage, monitor and counsel patients on tobacco treatment. Material will be presented via lectures, case presentations, discussions and out-of-class activities. PHTH 9049 PHTH7040 (5FS.F) PHDD8040 Critical Care Therapeutics (P only) Dental Problems and the Pharmacist Development and Manufacturing of Drug Products and Medical Devices The pathophysiology, pharmacology, and decision making processes for the treatment of patients who are critically ill. An overview of dental health and its relationship with pharmacy This course is designed to provide an understanding of the studies conducted in support of the development of drug product (formulation/dosage form) and medical devices necessary to seek regulatory approval. An emphasis will be placed on pre-formulation/formulation studies for optimizing lead compounds during early stages of drug development, current good manufacturing practices (cgmp) and FDA/ICH guidelines for formulation components, processes and equipment, stability testing programs and overall quality assurance. Special aspects of formulation of biologicals and medical devices will also be discussed. PHDD 800 Discovery of Drugs and Therapeutic Biologicals This course is an introduction to the discovery and early development (ie, prior to pre-clinical) of small molecule therapeutics and biopharmaceuticals such as proteins, peptides, vaccines, cell and gene therapies, and nucleotide based products. Introductions to the major classes and categories of drugs and biological will be provided including some principles of pharmacology such as drug targets/receptors and drug-receptor interactions. Methods and principles of drug/biologics discovery will be addressed from serendipitous observation to current approaches such as HTS, computational, combinatorial chemistry, and bioinformatics. Comparison of manufacturing methodology of drugs and biologics will be provided along with special clinical and regulatory considerations for biologic products. Additionally, emphasis will be given to major therapeutic areas (oncology, CNS, cardiovascular, Infectious Diseases/AIDS) in terms of approaches currently in use and in development along with addressing the unmet needs in each area.

PHTH 8090 Evaluation and Selection of Cardiovascular Agents This elective is a self -study course that involves writing a 0-page (approximately) paper that either evaluates the role of a new cardiovascular drug in therapy. The topic should be focused and go beyond the material offered in the prerequisite. PHCS 704 Financial Realities An informative course that provides students with the knowledge, skills, and tools that are needed to prepare them for lifelong learning and personal financial planning. PHDD 800 Global Regulatory and Development Strategies of Drugs and Medical Devices This course provides graduate students with an overview on legal and regulatory aspects relevant to drug and medical device development. This includes intellectual properties protection, global legal and regulatory requirements, protection of human subjects, ethics in clinical research, and essential elements of management of global projects. Case studies will be included to underline how regulatory strategies impact product marketing and life cycle management. Throughout the course, students will integrate knowledge using specific industry examples with the goal to identify critical decision points in the development that impact success of a new drug/medical device on the market. PHRX 7060 History of This course introduces the student pharmacist to the history of the profession and the University of Cincinnati College of. The course focuses on the historical development of pharmacy in the United States, Ohio, and Cincinnati through an examination of the growth and professionalization of the discipline, its commercial and industrial growth, institutional settings, its statutory regulation, and product development. PHRX 8045 PHRX 7045 (5FS.F) PADM 700 PHRX 706 Interprofessional Collaboration in Healthcare Medical Ethics & Movies Medication Use System Analyses and Improvement in World War II Interprofessional elective using a hybrid model. Students from pharmacy, nursing, pharmacy, and allied health will meet for 4 interactive class sessions during the semester. Participants will engage in one experiential activity in the community. All other activities, assignments, and discussions will be completed on-line. An interactive and engaging elective used to examine, discuss and reflect on medical ethical issues using the perspective portrayed in popular movies and to encourage diversity of viewpoints on these medical ethical issues Note: This class only meets for the first 7 class periods of the semester. Medication use system analysis, system improvement, pharmacy automation, quality assurance, utilization of pharmacy staff, facility design, and lean process. In 998 Tom Brokaw described the generation during World War II as America s greatest generation. It grew up during the depression and went on to fight and win a global war. was an integral part of the times. Pharmacists on the home front were as engaged in the global struggle as were their counterparts in the military. The course offered during the spring semester, in World War II will first provide the back story beginning with the Revolutionary War, through the Civil War and then

PHCS 7049 PHRX 7048 PHDD 8050 PHDD 800 Informatics Practice for Geriatric Patients Phase I/II Clinical Trials Research and Design Pre-Clinical/Non- Clinical Studies for IND approval focusing on the 940s. The stories of pharmacy on the home front include rationing, war drives, production, and changes in education. The military stories will include the battle for governmental recognition of pharmacy as a profession, pharmacy in many settings including combat, and pharmacists who went in harm s way. The stories of the Cincinnati College of and its alumni will provide local insights into the global picture. At the conclusion of the course the student will have an appreciation of pharmacy s greatest generation. Contributes to the students understanding of the importance of and ability to collect, organize, store, retrieve and analyze information about patients, medications, disease states and the medication use process. The course will help the student understand how knowledge is created from this information for healthcare providers, the patient, insurers and others involved in improving healthcare and medication use. Overview of geriatric and long term patient care. Highlights pharmacist s role, major responsibilities and opportunities available. This course will provide an understanding of the early clinical drug development activities for new chemical entities that have received IND approval. Concepts of early clinical pharmacology studies, typically conducted in a Phase I setting, such as single and multiple dose pharmacokinetics, dose escalation studies to determine the safety and tolerability of drugs, mass balance and drug metabolism studies, and bioavailability studies, will be taught. Emphasis will then be placed on Phase II clinical trials as key proof-of-concept studies, and on the dose-ranging requirements for Phase II. Trial designs, including cross-over and parallel group, will be discussed. The importance of Phase I/II trials for making dose selections for Phase III studies will be explored, as will the use of Phase II trials as a go/no-go decision point. The importance of exposure-response (PK/PD) information in guiding the go/no-go decision will also be discussed. The use of biomarkers and pharmacogenomic information in decision making will be addressed. The course is designed to teach students regulatory framework for the pre-clinical evaluation of the safety and efficacy of a molecular entity/lead compound identified in the drug discovery/early development phases for submission of the IND application. Major emphasis will be placed on the principles of pharmacokinetics/toxicokinetics and ADME processes (Absorption, Distribution, Metabolism and Excretion) so that safe (and efficacious) dosing regimens can be recommended for the early clinical development phases. Differences between conventional (small molecules) vs. macromolecules and biologicals will be underscored.

PHID 700 Research in Pharmaceutical Sciences This represents an independent study with a faculty member performing research in their lab or in outcomes research with databases. You MUST have made contact with a faculty member who is interested in mentoring you with research BEFORE registering for the course. Variable PHRX 904 PHDD 8060 PHTH 904 PHRX 7096 (5FS.F) PHRX 7095 00 Residency Preparation Seminar (P only) Statistical Principles in Clinical Research Substances of Abuse and Addictive Disorders Teaching and Learning in Education (P only) Veterinary This course is intended to actively improve skills necessary for students to be competitive for admission into residency programming with emphasis on interviewing, professional communication, critical thinking and familiarity with the residency application process. The course is designed to teach the statistical principles involved in designing clinical research studies to support new drug development programs. Statistical analysis techniques commonly used will be discussed as well as the newer approaches being considered. Statistical topics addressed in regulatory guidelines will be discussed. Emphasis will be placed on the use of statistical software such as JMP. Hands on exercises using the latest version of JMP will be conducted in various classes. This is an introductory course that examines the disease of addiction, including its diagnosis, treatment, as well as factors that contribute to the disease. In addition, the pharmacology of various drugs of abuse will be examined, with particular emphasis on their mechanism(s) of action. This course will provide the student with an overview of the academic profession of pharmacy as a career. Topics will include preparation and training for a career in pharmacy education, roles and responsibilities of faculty members, and accreditation standards and process. In addition to lectures, journal club discussions and a curricular review project will be assessed. Note: This class will meet every other week for 7 total sessions. This -credit elective course is designed to familiarize students with the basics of veterinary pharmacology, focusing on information needed to dispense and compound veterinary prescriptions in a community pharmacy setting.